Efficacy and safety of dexamethasone during the perioperative period of total hip arthroplasty

Efficacy and safety of two doses of dexamethasone for total hip arthroplasty during perioperative period

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039487

Enrollment

Unknown

Registered

2020-10-30

Start date

2020-11-01

Completion date

Unknown

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

orthopedic surgery

Interventions

Dexa Group:dexamethasone

placebo group:Saline

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients undergoing unilateral total hip arthroplasty for the first time;Agree to accept the trial and sign informed consent patients.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Allergic to dexamethasone;Patients with alcohol and drug abuse;Patients younger than 18 years old or older than 75 years old;Patients who had taken glucocorticoid 3 months before surgery;Patients taking strong opioids one week before surgery;Patients with severe heart disease (NYHA > 2) and liver and kidney failure;7 patients with rheumatic diseases (rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, etc.)

Design outcomes

Primary

Measure	Time frame
Pain;PONV;	—

Countries

Ching

Contacts

Public ContactLi Fulin

Guangxi Zhuang Autonomous Region People's Hospital

709184237@qq.com+86 17758648038

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026